Short Biography
Education and key qualifications
2009 Professor of Medicine in Oncology
Comité National Universitaire
2018 Accreditation as research director (HDR), Population Genetics
Université Paris Diderot, France
1994 PhD in fundamental bases of oncogenesis
Curie Institute, Gilles Thomas laboratory, Paris
1994 Medical specialty: Internal Medicine
Curie Institute, Gilles Thomas laboratory
1987-1994 Residency in Internal Medicine and Oncology, Paris
• Current position(s)
Since 2019 Director, Centre de recherche des Cordeliers, Paris
Since 2009 Professor, Université Paris Cité, Oncology, Paris
Since 2009 Praticienne Hospitalière, APHP, HEGP Hospital, Paris
Since 2007 Team leader, Functional genomics of solid tumors, Paris
Since 2022 Member of the National deontology college at the French Ministry of Research
Since 2025 Member of the HCERES college
Since 2025 Chair of the Ligue Nationale Contre le Cancer scientific committee Ile de France
• Previous position(s)
2022-2023 President of the International Liver Cancer Association (ILCA)
2019-2024 Member of the FNRS committee for physiology and Cancer
2012-2016 Chair of the national Inserm scientific committee for Cancer, Genetics and Bioinformatics
2020-2022 Chair of the Foundation ARC Committee for Research Orientation
2004-2009 Inserm Director of Research (DR2->DR1), Paris
1998-2004 Inserm Research Scientist (CR1), Paris
• Editorial activities
JHEP Reports new OA journal EASL, Geneva 2018 2023 Editor-in-Chief (IF 2022=9.9)
Journal of Hepatology, EASL, Geneva 2014 2019 Senior Editor JHEP (IF 2022=30)
Journal of Hepatology, EASL, Geneva 2010 2014 Associate Editor JHEP (IF 2014=10)
• Prizes and Awards
1993 French academy of science, Award Eugène et Amélie Dupuis
1998 Award young researcher Ligue Nationale Contre le Cancer
2004 French Academy of Science, Award René Turpin for cancer research
2012 Award Inserm Research
2014 Elected fellow of the European Academy of Cancer Sciences
2015 Award Charles Oberling
2016 « Coups d’élan » Fondation Schueller-Bettencourt
2018 René et André Duquesne, Comité de Paris Ligue Contre le Cancer
2018 Chevalier de la Légion d’honneur
2019 Ismar Boas Medal, Germany
2019 Docteur Honoris Causa Université Catholique de Louvain
2021-2025 Awarded by Clarivate “most highly cited researcher”
2021 French Academy of Medicine, Albert 1er de Monaco Award
2024 Lucie Bolte Prize, Hannover, Germany
2025 EASL European Association for study of the Liver: Recognition award, Amsterdam
• Invited lectures
More than 260 invited lectures at international meetings (EACR keynote speaker 2024, AACR, ASCO GI, EASL, AASLD, EMBO, FASEB, Keystone, Falk symposium, Leopoldina symposium, CRCL, APASL, Forbeck Forum,... ) or international institutes and universities (Mayo Clinic, Mount Sinai NY, Yale, Rockefeller NY Univ, NIH-NCI, NCC Singapore, UCLondon, Frukfurt univ, Newcastle Univ, CNIO, Asan Hospital, Taiwan Univ, Tel Aviv Univ, Scripps…)
• Reviewer for >50 journals including Nature, Nature Medicine, Nature Genetics, Nature Review Cancer, Nature Communications, Cell, Cancer Cell, Cancer Discovery, Lancet, Lancet Oncology, Clinical Cancer Research, Gastroenterology, Gut, Hepatology, JAMA, Journal of Clinical Investigation, Journal of Clinical Oncology, Journal of Experimental Medicine, Journal of Hepatology, PNAS, Science Translational Medicine.
• Teaching activities and mentoring
Member or chair of jury for ~60 PhD or HDR jury committees between 2002 and 2024
Between 1997 and 2024, supervision of 18 post-doctorates, 26 PhD students, and 21 master Students. Among them, ~30 are researchers in university laboratories and/or hospitals, ~8 are researchers in private companies.
• Co-organizer of international scientific conferences including
ILCA annual meetings 2015-2023 (400 to 900 participants each year); French-NTU symposium, Taiwan 2024; Holistic integrative Oncology, China 2024; EASL symposium 2024; AACR symposium 2022; EASL Basic Science Course 2020; Vice-Chair and chair of the Steering committee of the SIG neoplasm at AASLD 2019-2021 organization of several symposia (American Association for Study of liver disease); 5th International Conference on Liver and Cardiovascular Science, Wuhan, China, April 2019; HCC Summit EASL 2019; Cold Spring Harbor Asia liver metabolism and cancer, April 2016, Suzhou, China; Gilles Thomas’ symposium 2015 et 2017; FASEB Liver Summer Conference 2012
